Biocon Biologics  /  Our Business  /  Global Biosimilars Portfolio  /  Bone Health & Others

BONE HEALTH & OTHERS

Bone Health & Others

Biocon Biologics’ portfolio of biosimilars includes Denosumab which is used to treat osteoporosis and cancer.

Denosumab

Preclinical

Clinical

Filed

Approved

Launched

Share